Boston BioProducts’ Post

I am excited to share one of our latest innovations: Pipeline's Assay Request Management (ARM) module! Designed to bring flexibility and efficiency to your drug discovery journey is yet another step forward in streamlining the discovery process. ARM allows scientists to run a wide range of assays while making the most of your existing platform investments. Pipeline's Drug Discovery Program Management platform guides researchers from Target Identification through Lead Optimization. Don't just take our word for it; check out our demo video: https://bit.ly/3H8CRGT We're incredibly excited about this new module and hope that it revolutionizes your drug discovery experience. Let us know your thoughts in the comments below! 💡 #DrugDiscovery #Innovation #Pipeline #AssayRequestManagement #aspenbiosciences

Nominating a molecule as a candidate drug is a decision followed by significant investments. It also represents one of the points along a molecule’s development path where it’s crucial to assemble data spread across multiple teams and molecule generations. This challenging task is made even more difficult by the nature of discovery workflows, which are evolving processes themselves. Compared to most downstream processes discovery projects can be unpredictable, making them more difficult to structure in a way that facilitates retrospective data assembly and analysis. This is a challenge that I have discussed with many biopharma teams, and it is, perhaps, most evident in the handover between different project phases. Some would even say that there is a “culture clash” that becomes evident when transitioning a candidate molecule from early development into the more regulated processes. Do you agree? What is lacking to facilitate an easy-to-trace discovery and development process?

With the wealth of innovation in the life science therapeutics sector, there is a strong desire to reduce risk. This has always been challenging because of the complexity of biological systems. For life science investors, assessing a potential drug's efficacy through direct biophysical binding in its physiological context is essential, rather than relying on empirical functional data that can be not actionable or difficult to translate further in the discovery process. Pelago Bioscience AB proudly sponsors today's Agile Leaders Forum workshop, where industry experts delve into how novel target technologies facilitate a "get it right the first time" mindset, especially in due diligence. Learn how we deliver actionable, physiologically relevant data early in the discovery process—reach out to us for more information! https://hubs.la/Q02t1nJM0 #DrugDiscovery #AgileLeaders #ModernDrugDiscovery

Your work in life science is as complex as it gets? Behind every scientific breakthrough is more than just data, statistics and results. It's the scientists whose curiosity, creativity and tenacity are the driving force behind this progress. Never alone, but with a partner they trust. At Sartorius, we understand the challenges and opportunities that our partners face, from research to drug development to production. And we'll work with them to help make their work easier by asking: How can we make it simpler for them? We’re in this together. We simplify the complex to make your work easier. https://lnkd.in/ed_dEEUi #SimplifyingProgress #LifeSciences #bioprocessing #InThisTogether

🚀 Exciting day exploring the Life Science Value Chain at FUJIFILM Diosynth Biotechnologies Denmark! 🌟   Grateful for the comprehensive tour of the DSM production facility. We were fascinated by the synergy between science, technology, and innovation. Every step in the production contributes to groundbreaking advancements in medicine and beyond. 🧪💡 Let’s continue our journey of learning and excellence in this dynamic industry! 😊 #peoplefirst #consultingengineers #digitaltransformation #projectservices #managementconsulting #projectmanagement #programmanagement #lifesciences #pharma #supplychain #valuechainmanagement #supplychainmanagement

With Trevor Martin of Mammoth Biosciences we chatted about his experiences in building a pharma oriented biotech. It was quite interesting to hear his perspective on the importance of internal pipelines and the difference between a service and maybe even software only biotech company (which only Schrödinger really made work) and one which builds assets. Thanks Trevor!

Reposting my morning post with a more legible article. 😁 Having spent the last week attending AusBiotech, I have had the opportunity to listen to various insights and thoughts on current biotech trends, successes and challenges. I decided to compile my learning and share with my network. So, here is an article summarising my thoughts on why the biotech industry needs to step outside the box for successful drug development. Thank you to all the speakers and panellists who generously and openly shared their experiences and knowledge with the participants. It was great to hear from investors, scientists and industry stakeholders and understand their point of view. #lifescience #biotech #drugdevelopment #qualitysystems #venturecapital

Interested in innovative upstream process development optimization and in-line process analytical technologies, come meet Culture Biosciences and 908 Devices at IFPAC. #processdevelopment #processoptimization #processanalytics #bioprocess

How to develop adherent cell culture processes...

Calling all researchers and industry leaders! Supercharge Your Drug Discovery at ChemTalks - FREE Event! Frustrated by information silos hindering your early-stage drug discovery? Join ChemTalks, a FREE one-day scientific conference on September 25th in Basel, Switzerland. 🇨🇭 Unlock Hidden Connections & Fast-Track Your Research: - Hear groundbreaking insights from industry leaders on using technology to bridge research silos. - Get an exclusive sneak peek at Chemaxon's upcoming product updates designed to empower your work. - Network with fellow researchers & experts to exchange ideas and build valuable connections. Why Attend ChemTalks? ✔ Free access to cutting-edge knowledge & industry insights. ✔ Learn how to bridge the gap and foster collaboration in chemical research. ✔ Be the first to know about Chemaxon's exciting new product roadmap. ✔ Get expert advice from renowned scientists and product managers. ✔ Leave with actionable takeaways to implement immediately. Don't miss it! Register here: https://lnkd.in/gPPX5dYU #ChemTalks #DrugDiscovery #Breakthroughs #Collaboration #Innovation #Switzerland